16 Analysts Have This To Say About Elevance Health
16 Analysts Have This To Say About Elevance Health
16位分析師對Elevance Health發表看法
Elevance Health (NYSE:ELV) has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，16位分析師對Elevance Health（紐交所：ELV）進行了分析，揭示了從看好到看淡的多種眼光。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $605.69, a high estimate of $649.00, and a low estimate of $557.00. Surpassing the previous average price target of $590.17, the current average has increased by 2.63%.
從分析師的12個月價格目標中可以看出，平均目標爲605.69美元，高估爲649.00美元，低估爲557.00美元。超過之前的平均價格目標590.17美元，當前的平均價格增長了2.63％。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
The standing of Elevance Health among financial experts becomes...
通過對最近分析師行...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。